Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin.

Davis, M J

Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin. [electronic resource] - British journal of rheumatology Oct 1989 - 410-3 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article

0263-7103

10.1093/rheumatology/28.5.410 doi


Adult
Double-Blind Method
Female
Humans
Immunoglobulin A--metabolism
Male
Middle Aged
Spondylitis, Ankylosing--drug therapy
Sulfasalazine--therapeutic use
alpha 1-Antitrypsin--metabolism